Emergent BioSolutions Inc.

EBS

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001919170-26-000009
Filing date: Mar 5, 2026
Earliest execution date: Mar 5, 2026
Reporting Owners: Glessner Coleen (EVP, Quality & Ethics, and CPL)
SEC Filing link

Summary

Type

Sell

Net shares

-8,199

% of shares

-7.30%

Amount (USD)

$69,199

Insider confidence score

22.5 out of 100

Negative

  • Large discretionary sell (≥1% of shares)
  • Significant sell amount ($50K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Tax_withhold

Date

2026-03-05

Code

F

Net shares

-8,199.0

Price per Share

$8.44

Amount (USD)

$69,199.56

Acquired/Disposed

Disposed

Shares Owned Before

112,307.0

Shares Owned After

104,108.0

Derivative Transactions ⓘ

Transaction 1

Security

Employee Stock Option (Right to buy)

Action

Grant

Date

2026-03-03

Code

A

Net shares

+44,834.0

Acquired/Disposed

Acquired

Shares Owned Before

249,613.0

Shares Owned After

294,447.0

Filing's footnotes

1. Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units

2. Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.